Jari A Laukkanen, Ilkka H A Heinonen, Earric Lee, Setor K Kunutsor, Ursula Schwab, Heikki Kainulainen, Urho Kujala, Jari E Karppinen, Eija K Laakkonen
{"title":"Effects of Sauna Bathing on NMR-Based Metabolomic Profiles.","authors":"Jari A Laukkanen, Ilkka H A Heinonen, Earric Lee, Setor K Kunutsor, Ursula Schwab, Heikki Kainulainen, Urho Kujala, Jari E Karppinen, Eija K Laakkonen","doi":"10.1016/j.mayocp.2026.11.006","DOIUrl":"https://doi.org/10.1016/j.mayocp.2026.11.006","url":null,"abstract":"<p><strong>Background: </strong>Frequent sauna bathing is associated with reduced risk of adverse cardiovascular outcomes. However, the biochemical pathways through which sauna bathing may exert its cardiovascular health effects remain unclear. We therefore investigated the effects of Finnish sauna bathing on various blood-based cardiometabolic biomarkers. Specifically, this study investigated how a single 30-minute Finnish sauna session (AS) and an 8-week exercise-plus-sauna intervention (ESS) influence circulating metabolomic biomarkers related to lipid and amino acid metabolism.</p><p><strong>Methods: </strong>The study included two complementary populations: (1) an acute sauna exposure study including 63 habitual sauna users with at least one cardiovascular risk factor, and (2) an 8-week randomized controlled trial (RCT) including 47 sedentary non-regular sauna users randomized to exercise, exercise plus sauna, and control arms. The exercise intervention consisted of concurrent training three times per week, with the sauna group additionally completing 15 min of post-exercise sauna bathing. Circulating metabolites were quantified using high-throughput 1H-NMR spectroscopy at multiple time points in the acute study and at baseline and post-intervention in the RCT.</p><p><strong>Results: </strong>AS produced consistent metabolic shifts, including significant reductions in concentrations of plasma triglycerides and VLDL particles, decreases in branched-chain and aromatic amino acids, and increases in ketone bodies, suggesting a metabolic pattern compatible with enhanced lipid utilization and a transient metabolic stress response. ESS resulted in additional improvements beyond exercise alone, including reductions in LDL particle number and concentration, greater decreases in VLDL subclasses, and increases in HDL particle size, suggesting additional metabolic effects when heat exposure is added to exercise training.</p><p><strong>Conclusions: </strong>Sauna bathing, as an example of heat exposure, induces favorable alterations in lipid and amino acid metabolism and when combined with regular exercise, augments longer-term improvements in lipoprotein profiles.</p>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149408089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eric B Lantz, Patrick Vanderboom, Kevin Koo, Paul J Jannetto, John C Lieske, Jeff Meeusen, Patrick L Day
{"title":"A Validated Artificial Intelligence Model Versus Urinary Supersaturation Alone for Predicting Kidney Stone Composition.","authors":"Eric B Lantz, Patrick Vanderboom, Kevin Koo, Paul J Jannetto, John C Lieske, Jeff Meeusen, Patrick L Day","doi":"10.1016/j.mayocp.2026.06.027","DOIUrl":"https://doi.org/10.1016/j.mayocp.2026.06.027","url":null,"abstract":"<p><strong>Objective: </strong>To develop and validate an artificial intelligence (AI) model that can identify kidney stone composition more accurately than the EQUIL2 urine supersaturation (SS) algorithm.</p><p><strong>Patients and methods: </strong>Patients with both a 24-hour urine SS panel and a kidney stone composition analysis conducted within 90 days of each other between September 24, 2015, and March 15, 2024, were identified (n=13,000 unique patients). Kidney stones were classified as either majority calcium oxalate (CaOx), majority calcium phosphate (CaP), uric acid, or other. A model was developed to predict kidney stone classification using demographic characteristics plus urinary SS panel results. This model was subsequently validated on a held-out data set of paired measurements collected between March 16, 2024, and March 15, 2025 (n=1653). The urinary SS for CaOx, hydroxyapatite (CaP), brushite (CaP), and uric acid were calculated using EQUIL2 according to routine clinical practice and expressed using the delta Gibbs free energy scale.</p><p><strong>Results: </strong>The AI model was significantly more accurate in the validation data set for identifying stone composition compared with SS alone (accuracy, 0.73 vs 0.33; P<.01). Additionally, the model outperformed SS alone in the validation data set for correctly identifying kidney stone composition in all analyses stratified into clinically relevant subgroups by age and sex.</p><p><strong>Conclusion: </strong>In all kidney stone categories and within various subgroups, the AI model outperformed the EQUIL2-calculated SS as well as previously published AI models in the correct prediction of CaOx, CaP, and uric acid kidney stones when using the 24-hour urine SS panel.</p>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Diet Quality Versus Physical Activity and Cardiorespiratory Fitness for Longevity: A Review of Comparative Evidence.","authors":"Glenn A Gaesser, Robert E Sallis","doi":"10.1016/j.mayocp.2026.10.010","DOIUrl":"https://doi.org/10.1016/j.mayocp.2026.10.010","url":null,"abstract":"<p><p>Poor diet quality and insufficient physical activity (PA) are major modifiable risk factors for chronic disease and a shortened lifespan. Public health priorities have historically emphasized dietary modification more than increasing PA, and this disproportionate emphasis persists in current initiatives. We searched PubMed for applicable articles to evaluate the relative associations of diet quality, PA, and cardiorespiratory fitness (CRF) with all-cause mortality (ACM). Evidence from meta-analyses and prospective cohort studies indicates that: (1) a sedentary lifestyle is associated with substantially greater excess mortality risk than poor diet quality; (2) lower ACM risk associated with high PA or CRF exceeds that associated with high adherence to healthy dietary patterns or greater consumption of plant-based foods; (3) increases in PA or CRF are associated with lower ACM risk than improvements in diet quality; (4) in studies examining joint associations, PA or CRF is more strongly associated with ACM than diet quality, with several studies showing that high PA or CRF largely eliminates excess mortality risk associated with lower diet quality; and (5) exercise prevents or attenuates adverse cardiometabolic and vascular effects of short-term unhealthy dietary challenges, whereas dietary interventions are largely ineffective in offsetting the physiological consequences of physical inactivity. These findings do not diminish the importance of a healthy diet but indicate that the disproportionate focus on diet relative to PA in current public health priorities is not supported by the comparative evidence. Collectively, the results support greater public health emphasis on increasing PA and improving CRF when the primary goals are longevity and reduction of chronic disease mortality.</p>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liselotte N Dyrbye, Mickey Trockel, Karl Bilimoria, John Bryan Sexton, Srijan Sen, Christine Sinsky, Jonathan Ripp, Tait D Shanafelt
{"title":"A National Research Agenda to Advance Physician Well-Being.","authors":"Liselotte N Dyrbye, Mickey Trockel, Karl Bilimoria, John Bryan Sexton, Srijan Sen, Christine Sinsky, Jonathan Ripp, Tait D Shanafelt","doi":"10.1016/j.mayocp.2026.11.002","DOIUrl":"https://doi.org/10.1016/j.mayocp.2026.11.002","url":null,"abstract":"<p><p>Physician well-being is increasingly recognized as essential to healthcare system performance, workforce sustainability, and the capacity for organizational change. However, healthcare systems continue to lack sufficiently evaluated, scalable strategies to advance well-being (meaning, purpose, professional fulfillment) and address challenges, including occupational burnout, depression, and workforce retention. In response to persistent gaps in knowledge regarding scalable solutions and organizational action, the Stanford Medicine WellMD & WellPhD Center convened a national Physician Well-Being Think Tank in 2025. The Think Tank brought together well-being researchers, chief wellness officers, and healthcare executives who reviewed current evidence, identified critical knowledge gaps, and completed pre-meeting prioritization activities, voted on high-priority evidence gaps, and engaged in iterative small-group and full-group consensus discussions to develop priorities for future research. Through this process, the group developed a research agenda focused on four prioritized domains: (1) strengthening causal evidence linking occupational well-being to core system outcomes, (2) evaluating scalable organizational interventions to improve clinician well-being, (3) advancing pragmatic operational strategies for cultivating wellness-centered leadership, and (4) generating evidence to inform optimal interdisciplinary clinical work design. The intent of this research agenda is to define the evidence needed to help accelerate system level action to drive improvement and enhance the long-term stability and performance of the healthcare workforce.</p>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149379549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Melanie Davies, Thomas E Padgett, Scott Goulden, Phil McEwan, Barrie Chubb, Joseph Whitaker, Kamlesh Khunti
{"title":"The Future Burden of Type 2 Diabetes and the Role of Glycaemic Control and GLP1-RAs.","authors":"Melanie Davies, Thomas E Padgett, Scott Goulden, Phil McEwan, Barrie Chubb, Joseph Whitaker, Kamlesh Khunti","doi":"10.1016/j.mayocp.2026.10.021","DOIUrl":"https://doi.org/10.1016/j.mayocp.2026.10.021","url":null,"abstract":"<p><strong>Objective: </strong>To assess the impact of glycaemic target achievement, both with and without optimal treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs), on the predicted burden of type 2 diabetes (T2D) and associated complications from a UK healthcare system and society perspective METHODS: A system dynamics model was developed to predict the prevalence and burden of T2D and associated complications, stratified by age and haemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>)<sub>,</sub> in the UK from 2024 to 2060. Two treatment scenarios were evaluated: Scenario A, representing population-wide attainment of glycaemic targets, and Scenario B, applying a population-wide GLP-1 RA effect in addition to glycaemic target attainment. The GLP-1 RA effect was modelled via hazard ratios applied to age- and HbA<sub>1c</sub>-stratified rates of micro- and macrovascular complications RESULTS: Following current trends, the prevalence of T2D is expected to rise from 3·7M (5·3%) in 2024 to 6·3M (5·5-7.3M; 8·3% [7·9-8·8%]) in 2060, with total yearly costs increasing from £20·7bn to £33·4bn. Scenario A resulted in total cumulative savings of £61·4bn by 2060, driven by reductions in the direct cost of complications. Scenario B prevented 4·5 times as many macrovascular complications and 6 times as many deaths as Scenario A, resulting in total cumulative savings of £140·7bn. Savings in Scenario B were driven by the monetary value of life-years saved.</p><p><strong>Conclusion: </strong>The cardiorenal protection afforded by GLP-1 RAs confers significant additional value compared with glycaemic control alone.</p>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.5,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149322816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mayo Clinic proceedingsPub Date : 2026-11-01Epub Date: 2026-05-27DOI: 10.1016/j.mayocp.2025.12.018
Weiming Wang MD, PhD, Jing Kang MD, PhD, Jiaxiang Shi MM, BS, Ruimin Jiao MD, PhD, Zhiwei Zang MD, Zilin Long MD, PhD, Xi Wang MS, BS, Xinkun Liu MM, BS, Yan Liu MD, PhD, Zhishun Liu MD, PhD
{"title":"Efficacy of Electroacupuncture Compared With Topical Diclofenac Sodium Gel for Patients With Hand Osteoarthritis: A Randomized Controlled Trial","authors":"Weiming Wang MD, PhD, Jing Kang MD, PhD, Jiaxiang Shi MM, BS, Ruimin Jiao MD, PhD, Zhiwei Zang MD, Zilin Long MD, PhD, Xi Wang MS, BS, Xinkun Liu MM, BS, Yan Liu MD, PhD, Zhishun Liu MD, PhD","doi":"10.1016/j.mayocp.2025.12.018","DOIUrl":"10.1016/j.mayocp.2025.12.018","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the effectiveness and safety of 4-week electroacupuncture (EA) compared with topical diclofenac sodium gel (DSG) for hand osteoarthritis (HOA).</div></div><div><h3>Patients and Methods</h3><div>Participants with symptomatic HOA for at least 3 months were randomly assigned to receive either 12 sessions of EA or topical DSG at a dose of 2 g 4 times per day for 4 weeks followed by a 12-week follow-up. The primary outcome was the change in the average overall finger joint pain intensity in the dominant hand during the previous 48 hours measured on the visual analog scale (0, no pain; 100, maximal pain) from baseline at week 4. The research period was from September 1, 2020, to March 17, 2024, and the statistical analyses were completed by March 15, 2025.</div></div><div><h3>Results</h3><div>A total of 120 (n=60 in each group) participants were included. The overall finger joint pain intensity measured with the visual analog scale in the dominant hand during the previous 48 hours at week 4 was 28.72 (95% CI, 24.21 to 33.23) in the EA group and 42.82 (95% CI, 38.32 to 47.33) in the DSG group (between-group difference, –14.11; 95% CI, –20.49 to –7.73; <em>P</em><.001). Similar between-group differences favoring EA were observed at week 8 and week 16. Treatment-related adverse events were rare, relatively mild, and transient in the trial.</div></div><div><h3>Conclusion</h3><div>Treatment of HOA with EA for 4 weeks had clinically meaningful effects on reducing pain compared with topical DSG, and the effects persisted through the 12-week follow-up. Electroacupuncture may be considered a promising nonpharmacologic therapy for HOA.</div></div><div><h3>Trial Registration</h3><div>ClinicalTrials.gov identifier: NCT04402047</div></div>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 11","pages":"Pages 1961-1975"},"PeriodicalIF":6.5,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148032434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mayo Clinic proceedingsPub Date : 2026-11-01Epub Date: 2026-07-02DOI: 10.1016/j.mayocp.2026.04.014
Kathryn T. del Valle MD, Kayla J. Kolbert MS, CGC, Kaitlin J. Sikkink MS, CGC, Chloe E. Gill MS, CGC, Jennifer L. Kemppainen MS, CGC, Allison M. LeMahieu MS, Amarilys D. Alarcon-Calderon MD, Kelly M. Pennington MD, Cassie C. Kennedy MD, MS, Andrew H. Limper MD, Alejandro Ferrer PhD, Abhishek A. Mangaonkar MBBS, David J. Murphy Carmona, Denise A. Whalen, Misbah Baqir MBBS, Diana J. Kelm MD, Ana C. Zamora MD, Mrinal S. Patnaik MD, PhD, Victor E. Ortega MD, PhD, Filippo Pinto e Vairo MD, PhD, Eva M. Carmona MD PhD
{"title":"Advancing Pulmonary Fibrosis Care","authors":"Kathryn T. del Valle MD, Kayla J. Kolbert MS, CGC, Kaitlin J. Sikkink MS, CGC, Chloe E. Gill MS, CGC, Jennifer L. Kemppainen MS, CGC, Allison M. LeMahieu MS, Amarilys D. Alarcon-Calderon MD, Kelly M. Pennington MD, Cassie C. Kennedy MD, MS, Andrew H. Limper MD, Alejandro Ferrer PhD, Abhishek A. Mangaonkar MBBS, David J. Murphy Carmona, Denise A. Whalen, Misbah Baqir MBBS, Diana J. Kelm MD, Ana C. Zamora MD, Mrinal S. Patnaik MD, PhD, Victor E. Ortega MD, PhD, Filippo Pinto e Vairo MD, PhD, Eva M. Carmona MD PhD","doi":"10.1016/j.mayocp.2026.04.014","DOIUrl":"10.1016/j.mayocp.2026.04.014","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the impact of genetic testing and telomere analysis among patients with fibrotic interstitial lung disease, we established a translational genetic testing and counseling unit for patients referred from our pulmonary practice.</div></div><div><h3>Patients and Methods</h3><div>We included patients referred to the genetic testing and counseling unit between 2019 and 2023 who presented either with a family history of pulmonary fibrosis, progressive fibrotic disease, clinical indicators of surfactant protein or telomere biology disorders (eg, early greying of hair, etc), or early-onset fibrosis (≤60 years). Patients underwent a pulmonary fibrosis–multigene sequencing panel and telomere length assessment. Clinical data, genetic sequencing results, and telomere measurements were collected and analyzed.</div></div><div><h3>Results</h3><div>Of 66 referred patients, 54 (82%) completed genetic testing. Common clinical diagnoses were unclassifiable fibrotic lung disease (29%) and idiopathic pulmonary fibrosis (26%). The predominant radiologic pattern was indeterminate for usual interstitial pneumonia (42%). Telomere lengths, measured in 47 patients (71%), were less than or equal to the 10th percentile in lymphocytes and/or granulocytes for age-matched controls in 37 patients (79%). Pathogenic/likely pathogenic variants were identified in 10 patients (19%), predominantly in telomere pathway genes (9 of 10 cases). Shorter lymphocyte telomere length increased odds of identifying a genetic etiology (odds ratio: 6.26; 95% CI: 1.50 to 33.83; <em>P</em> = .01). Importantly, genetic findings impacted clinical decisions in more than half of tested patients.</div></div><div><h3>Conclusion</h3><div>Comprehensive genetic sequencing combined with telomere length analysis enhances diagnostic accuracy in fibrotic interstitial lung disease, identifying a high proportion of cases attributable to telomere disorders. Our integrated clinical model demonstrates significant translational value, influencing patient management, and therapeutic decision-making.</div></div>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 11","pages":"Pages 1945-1960"},"PeriodicalIF":6.5,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148369046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mayo Clinic proceedingsPub Date : 2026-11-01Epub Date: 2026-07-28DOI: 10.1016/j.mayocp.2026.07.021
William D. Farrar MD, Nathan H. Farrar, Adil E. Bharucha MBBS, MD
{"title":"Diverticulitis Incidence in a Rural Population","authors":"William D. Farrar MD, Nathan H. Farrar, Adil E. Bharucha MBBS, MD","doi":"10.1016/j.mayocp.2026.07.021","DOIUrl":"10.1016/j.mayocp.2026.07.021","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 11","pages":"Pages 2071-2073"},"PeriodicalIF":6.5,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148605007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mayo Clinic proceedingsPub Date : 2026-11-01Epub Date: 2026-08-12DOI: 10.1016/j.mayocp.2025.12.025
Jairo S. Hernandez MD, Jennae N. Shelby MD, PhD, Brenden S. Ingraham MD
{"title":"78-Year-Old Presenting With Aphasia and Visual Hallucination","authors":"Jairo S. Hernandez MD, Jennae N. Shelby MD, PhD, Brenden S. Ingraham MD","doi":"10.1016/j.mayocp.2025.12.025","DOIUrl":"10.1016/j.mayocp.2025.12.025","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 11","pages":"Pages 2053-2058"},"PeriodicalIF":6.5,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148713104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mayo Clinic proceedingsPub Date : 2026-11-01Epub Date: 2026-09-12DOI: 10.1016/j.mayocp.2025.12.023
Agata K. Sularz MB BChir, Stefan L. Farrugia MD, Richard M. Elias MBBS, MPH
{"title":"83-Year-Old Woman With Abdominal Distention and Lower Limb Swelling","authors":"Agata K. Sularz MB BChir, Stefan L. Farrugia MD, Richard M. Elias MBBS, MPH","doi":"10.1016/j.mayocp.2025.12.023","DOIUrl":"10.1016/j.mayocp.2025.12.023","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 11","pages":"Pages 2063-2068"},"PeriodicalIF":6.5,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148956065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}